Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Biomaterials ; 282: 121390, 2022 03.
Article in English | MEDLINE | ID: mdl-35124515

ABSTRACT

The IEELEEELEAER peptide (PIE) identified from the protein hydrolysate of Mytilus edulis is reported to enhance osteoblast growth and differentiation, which also possesses a superior bone formation ability both in vitro and in vivo. Moreover, PIE bound to calcium spontaneously at the stoichiometry of 1:1, and there were amino nitrogen and carboxyl oxygen atoms in 2 glutamic acid residues at the calcium-binding sites in the PIE. The PIE-calcium complex facilitated calcium uptake through the Caco-2 cell monolayers. Incorporation of PIE into calcium phosphate cements enhanced calcium ion uptake and proliferation of osteoblasts and inhibit bacteria. This study suggest that calcium phosphate cements supplemented with PIE can serve as a potentially efficient material for bone graft used during spinal surgery.


Subject(s)
Calcium , Mytilus edulis , Animals , Bone Cements/chemistry , Caco-2 Cells , Calcium/metabolism , Calcium Phosphates/chemistry , Humans , Mytilus edulis/chemistry , Mytilus edulis/metabolism , Osteoblasts/metabolism , Peptides/chemistry
2.
Eur J Pharm Biopharm ; 85(1): 130-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23680585

ABSTRACT

Four cement applications were tested in this investigation. Two dicalcium phosphate dihydrate (DCPD-brushite) hydraulic cements, an apatite hydraulic fiber loaded cement, and a calcium sulfate cement (Plaster of Paris) were implanted in epiphyseal and metaphyseal cylindrical bone defects in sheep. The in vivo study was performed to assess the biocompatibility and bone remodeling of four cement formulations. After time periods of 2, 4, and 6 months, the cement samples were clinically and histologically evaluated. Histomorphometrically, the amount of new bone formation, fibrous tissue, and bone marrow and the area of remaining cement were measured. In all specimens, no signs of inflammation were detectable either macroscopically or microscopically. Cements differed mainly in their resorption time. Calcium sulfate was already completely resorbed at 2 months and showed a variable amount of new bone formation and/or fibrous tissue in the original drill hole over all time periods. The two DCPD cements in contrast were degraded to a large amount at 6 months, whereas the apatite was almost unchanged over all time periods.


Subject(s)
Biocompatible Materials , Bone Cements/therapeutic use , Bone Regeneration , Bone Remodeling , Bone and Bones/surgery , Absorption , Animals , Animals, Inbred Strains , Biocompatible Materials/adverse effects , Bone Cements/adverse effects , Bone Cements/chemistry , Bone and Bones/cytology , Bone and Bones/injuries , Bone and Bones/physiology , Calcium Phosphates/administration & dosage , Calcium Phosphates/adverse effects , Calcium Phosphates/chemistry , Calcium Phosphates/therapeutic use , Calcium Sulfate/administration & dosage , Calcium Sulfate/adverse effects , Calcium Sulfate/chemistry , Calcium Sulfate/therapeutic use , Epiphyses/injuries , Epiphyses/surgery , Female , Foreign-Body Reaction/prevention & control , Injections, Intralesional , Sheep, Domestic , Solubility , Time Factors , Viscosity
SELECTION OF CITATIONS
SEARCH DETAIL